Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of ($0.11), versus ($0.05) reported last year. Revenue for the quarter came in at $8.5 million versus the consensus estimate of $9.16 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.